A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
Clinical trial NCT05371652 · COMPLETED
Trial details
- NCT number
- NCT05371652
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2024-02-06
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.